Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
Hoda MA, Klikovits T, Arns M, Dieckmann K, Zöchbauer-Müller S, Geltner C, Baumgartner B, Errhalt P, Machan B, Pohl W, Hutter J, Eckmayr J, Studnicka M, Flicker M, Cerkl P, Klepetko W. Hoda MA, et al. Among authors: eckmayr j. Wien Klin Wochenschr. 2016 Sep;128(17-18):618-26. doi: 10.1007/s00508-016-1036-3. Epub 2016 Jul 25. Wien Klin Wochenschr. 2016. PMID: 27457872 Free PMC article.
Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database.
Klikovits T, Hoda MA, Dong Y, Arns M, Baumgartner B, Errhalt P, Geltner C, Machan B, Pohl W, Hutter J, Eckmayr J, Studnicka M, Flicker M, Cerkl P, Kirchbacher K, Klepetko W. Klikovits T, et al. Among authors: eckmayr j. Wien Klin Wochenschr. 2016 Sep;128(17-18):627-34. doi: 10.1007/s00508-016-1037-2. Epub 2016 Jul 25. Wien Klin Wochenschr. 2016. PMID: 27457873 Free PMC article.
Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
Geltner C, Errhalt P, Baumgartner B, Ambrosch G, Machan B, Eckmayr J, Klikovits T, Hoda MA, Popper H, Klepetko W; Austrian Mesothelioma Interest Group (AMIG). Geltner C, et al. Among authors: eckmayr j. Wien Klin Wochenschr. 2016 Sep;128(17-18):611-7. doi: 10.1007/s00508-016-1080-z. Epub 2016 Sep 12. Wien Klin Wochenschr. 2016. PMID: 27619223 Free PMC article.
[Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms].
Hilbe W, Aigner K, Dittrich C, Eckmayr J, Fiegl M, Flicker M, Forstner B, Greil R, Jamnig H, Krajnik G, Lang A, Mohn-Staudner A, Schinko H, Studnicka M, Pirker R, Ploner F, Rothmund J, Schiller L, Zabernigg A, Zöchbauer-Müller S. Hilbe W, et al. Among authors: eckmayr j. Wien Klin Wochenschr. 2007;119(7-8):259-66. doi: 10.1007/s00508-007-0792-5. Wien Klin Wochenschr. 2007. PMID: 17492355 Review. German. No abstract available.
Results of the Austrian National Lung Cancer Audit.
Burghuber OC, Kirchbacher K, Mohn-Staudner A, Hochmair M, Breyer MK, Studnicka M, Mueller MR, Feurstein P, Schrott A, Lamprecht B, Eckmayr J, Renner F, Bolitschek J, Pohl W, Schenk P, Errhalt P, Cerkl P, Baumgartner B, Kneussl M, Hartl S. Burghuber OC, et al. Among authors: eckmayr j. Clin Med Insights Oncol. 2020 Sep 10;14:1179554920950548. doi: 10.1177/1179554920950548. eCollection 2020. Clin Med Insights Oncol. 2020. PMID: 32963472 Free PMC article.
[Masterplan 2025 of the Austrian Society of Pneumology (ASP)-the expected burden and management of respiratory diseases in Austria].
Studnicka M, Baumgartner B, Bolitschek J, Doberer D, Eber E, Eckmayr J, Hartl S, Hesse P, Jaksch P, Kink E, Kneussl M, Lamprecht B, Olschewski H, Pfleger A, Pohl W, Prior C, Puelacher C, Renner A, Steflitsch W, Stelzmüller I, Täubl H, Vonbank K, Wagner M, Wantke F, Wass R. Studnicka M, et al. Among authors: eckmayr j. Wien Klin Wochenschr. 2020 Sep;132(Suppl 3):89-113. doi: 10.1007/s00508-020-01722-w. Wien Klin Wochenschr. 2020. PMID: 32990821 German.
[Struma--goiter--lung function].
Mösenbacher A, Mayer KH, Stockhammer M, Leitner L, Eckmayr J. Mösenbacher A, et al. Among authors: eckmayr j. Wien Med Wochenschr Suppl. 1989;104:suppl 47-8. Wien Med Wochenschr Suppl. 1989. PMID: 2588634 German. No abstract available.
Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial).
Kocher F, Pircher A, Mohn-Staudner A, Romeder F, Duller W, Steinmaurer M, Eckmayr J, Schmid T, Hilbe W, Fiegl M, Greil R. Kocher F, et al. Among authors: eckmayr j. Lung Cancer. 2014 Sep;85(3):395-400. doi: 10.1016/j.lungcan.2014.06.019. Epub 2014 Jul 3. Lung Cancer. 2014. PMID: 25043642 Clinical Trial.
Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer.
Manegold C, Vansteenkiste J, Cardenal F, Schuette W, Woll PJ, Ulsperger E, Kerber A, Eckmayr J, von Pawel J. Manegold C, et al. Among authors: eckmayr j. Invest New Drugs. 2013 Feb;31(1):175-82. doi: 10.1007/s10637-012-9842-6. Epub 2012 Jul 3. Invest New Drugs. 2013. PMID: 22752690 Free PMC article. Clinical Trial.
[Nonspecific bronchial provocation: a comparison of 2 methods].
Mayer KH, Leitner L, Mösenbacher A, Eckmayr J. Mayer KH, et al. Among authors: eckmayr j. Wien Med Wochenschr Suppl. 1989;104:suppl 39-40. Wien Med Wochenschr Suppl. 1989. PMID: 2588626 German. No abstract available.
26 results